190 related articles for article (PubMed ID: 32296668)
1. Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis.
Wang Y; Pan W; Zhao D; Chen Y; Chen X; Xia H
Front Pediatr; 2020; 8():131. PubMed ID: 32296668
[No Abstract] [Full Text] [Related]
2. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
Dong H; Xu C; Zhou W; Liao Y; Cao J; Li Z; Hu B
Clin Chim Acta; 2018 Aug; 483():145-150. PubMed ID: 29709450
[TBL] [Abstract][Full Text] [Related]
3. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
4. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Ma HY; Dong L; Quan SZ; Li RY; Wang XR
Ann Palliat Med; 2021 Apr; 10(4):4108-4121. PubMed ID: 33832299
[TBL] [Abstract][Full Text] [Related]
6. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B.
Li F; Zhu CL; Zhang H; Huang H; Wei Q; Zhu X; Cheng XY
Braz J Infect Dis; 2012; 16(1):9-14. PubMed ID: 22358349
[TBL] [Abstract][Full Text] [Related]
7. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
[TBL] [Abstract][Full Text] [Related]
8. Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.
Mosca A; Comparcola D; Romito I; Mantovani A; Nobili V; Byrne CD; Alisi A; Targher G
Liver Int; 2019 Dec; 39(12):2317-2329. PubMed ID: 31436362
[TBL] [Abstract][Full Text] [Related]
9. [Serum fibrosis markers in diagnosing liver fibrosis].
Liu J; Wang JY; Lu Y
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
[TBL] [Abstract][Full Text] [Related]
10. Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis.
Lee MH; Shin HJ; Yoon H; Han SJ; Koh H; Lee MJ
World J Gastroenterol; 2020 Jun; 26(21):2821-2830. PubMed ID: 32550757
[TBL] [Abstract][Full Text] [Related]
11. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
[TBL] [Abstract][Full Text] [Related]
12. Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study.
Qi X; Li H; Chen J; Xia C; Peng Y; Dai J; Hou Y; Deng H; Li J; Guo X
Gastroenterol Res Pract; 2015; 2015():274534. PubMed ID: 26770190
[TBL] [Abstract][Full Text] [Related]
13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
14. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
Yang LY; Fu J; Peng XF; Pang SY; Gao KK; Chen ZR; He LJ; Wen Z; Wang H; Li L; Wang FH; Yu JK; Xu Y; Gong ST; Xia HM; Liu HY
World J Gastroenterol; 2015 May; 21(19):5893-900. PubMed ID: 26019453
[TBL] [Abstract][Full Text] [Related]
15. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
16. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
17. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Larrousse M; Laguno M; Segarra M; De Lazzari E; Martinez E; Blanco JL; León A; Deulofeu R; Miquel R; Milinkovic A; Lonca M; Miró JM; Biglia A; Murillas J; Gatell JM; Mallolas J
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):304-11. PubMed ID: 18172937
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
[TBL] [Abstract][Full Text] [Related]
20. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
